GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » S2Medical AB (OSTO:S2M) » Definitions » 3-Year Sharpe Ratio

S2Medical AB (OSTO:S2M) 3-Year Sharpe Ratio : 0.11 (As of Jul. 07, 2025)


View and export this data going back to 2018. Start your Free Trial

What is S2Medical AB 3-Year Sharpe Ratio?

The 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. As of today (2025-07-07), S2Medical AB's 3-Year Sharpe Ratio is 0.11.


Competitive Comparison of S2Medical AB's 3-Year Sharpe Ratio

For the Medical Instruments & Supplies subindustry, S2Medical AB's 3-Year Sharpe Ratio, along with its competitors' market caps and 3-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


S2Medical AB's 3-Year Sharpe Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, S2Medical AB's 3-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where S2Medical AB's 3-Year Sharpe Ratio falls into.


;
;

S2Medical AB 3-Year Sharpe Ratio Calculation

The 3-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last three years. A stock / portfolio's 3-Year Sharpe Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past three years.


S2Medical AB  (OSTO:S2M) 3-Year Sharpe Ratio Explanation

The 3-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past three years. It is calculated as the annualized result of the average three-year monthly excess returns divided by its standard deviation in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


S2Medical AB 3-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of S2Medical AB's 3-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


S2Medical AB Business Description

Traded in Other Exchanges
Address
Sunnorpsgatan 5, Linkoping, SWE, 582 73
S2Medical AB is a research-intensive MedTech company from Sweden. The company has developed several unique wound care products and has many disruptive technologies in the pipeline. Its products include wound debridment, blood stilling, skin grafting, tissue substitutes, bandage, and antimicrobial.

S2Medical AB Headlines

No Headlines